Clinical Information

. Clinical Findings:

Performance Scale (Karnofsky Score):
’ 1:1 100 Asymptomatic Cl 80-90 Symptomatic but Fully Ambulatory El 60-70 Symptomatic, in bed less than 50% of day

:44 0-50 S m tomatic, in bed more than 50% of da , but not bed ridden E] 20-30 Bed Ridden

 

V ICAL- HISTO
Disease Disorder

Date Treatment

Status

 

 

    
 
     

OBIGYN;HISTOR¥:

Date of First Menses

pm r ’l/ MW W
Date of Last Menses

. l
l) (m *l‘rx LWm M194,
Cl Oral Contraceptive pal IUD

 

Menopausal Status
Cl Pre—menopausal

 

 

El Peri-Menopausal
. $Post—menopausal
Birth Control: El Condom

D Other:

 

 

 

 

 

Therapy:

 

 

Environmental Hazards:
Smoki H

Current Status Packs

El YES

Duration

Alcohol Consum

Current Status Drinks

Cl YES

Duration

Use

Current Status
El YES NO

Duration

Relative

 

 

 

    
       

 

Test Result Result

 

 

 

 

 

 

 

 

 

 

 

HIV \g Negative El Positive:
Hep B @Negative El Positive:
Hep C wNegative CI Positive:

AFP El Negative I3 Positive:
Other: [I Negative El Positive:

B/T Cell Markers:

 

 

 

 

 

CEA D Negative III Positive:
CA 15-3 1:! Negative El Positive:
CA 19-9 13 Negative D Positive:

PSA El Negative 1:] Positive:

Other: El Negative [3 Positive:

 

 

 

 

 

 

 

 

 

  

Ultrasound
X-Ra

CT
Endosco
iMRI
Bi

 
 
      
   
 
 

  
  
 

 

< GLINICAEDIAGNOSIS
Preoperative Clinical Diagnosis

 

 

 

 

 

 

 

 

 

Location of Suspected Involved Lymph Nodes Location of Suspected Distant Metastasis
Clinical Stagi_ng
T 3 N f M ﬁ Stage: 7]]

 

 

 

reatment Information!

 

Procedure

\-\ V \
ma Tumor
Detailed Location

24
Extension Tumor

L Nodes
Location of L Nodes # of L Nodes

Palpable, Non—Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed LOCation

Su ical
N M

reatment Route

 

 

 

Frozen Parafﬁn Block Blood/Serum/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal

Time to LN2 Time to Formalin Time to LN2

Prima Tumor
Size Extension of Tumor Distance to NAT

x ”X cm 8 A cm

h Nodes
Location # Exa # Metastasized

Distant Metastasis
Detailed

Pathol icalS in
pT N M y Stage:

34%wagf ﬂétagé‘g 2 {/M’yﬁﬂ)

 

 

1.

CELL DISTRIBUTION
Diffuse STRUCTURAL PATTERN

Mosaic
NCCTOSiS Fibrosis
L Inﬁltration

Vascular invasion

Clusterized

Alveolar
File

Storiform

   

 
 

_ Psammoma/Calciﬁeation l I I

 

 

 

 

 

 

 

 

2. Cellular features:
Squamous + - Adenomatous + - Sarcomatous + - Lymphomatous + -
uamoid Cell Glandular cell A, Round Cell Large_Cell
S indie Cell Cell Stratiﬁcation % Fibroblast Small Cell
Kemtin Secretion Ostcoblast RS Cell/RS Like
Desmosome lntracyt. Vacuole a Lipoblast lnﬂam. Cell
Pearl Gland formation K Myoblast Plasma Cell

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Otherwise Speciﬁed: PI 7 2:2 2“] (DZ 9?: (3% $9 60:2 , 3%

2. Cellulaqu'ﬂ'eumiation:
Well Moderately Poor

X

 

 

 

 

 

 

 

 

Nuclear

 

3.

     
   
 

  
 

   

Multinucleated

Cell
Mitotic '

